Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Estrus”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 199 records · Page 11Linked to original sources
PubMed2001

Seasonal variation in preovulatory events associated with synchronization of estrus in dwarf goats.

This experiment was conducted to define the temporal relationships among estrus, the LH surge and ovulation after estrus synchronization in dwarf goats and to assess the effect of season on these parameters. In November (breeding season), March (transition period) and July (non-breeding season), estrus was synchronized in 12 dwarf goats by means of intravaginal sponges containing 60 mg medroxyprogesterone acetate (MAP) for 10 d, coupled with 125 microg cloprostenol i.m. 48 h before sponge removal and 300 IU eCG i.m. at sponge removal. A different group of animals was used during each time period. Onset of estrus was monitored using two males, and blood samples for the measurement of plasma LH were collected at 2-h intervals from 24 to 60 h after sponge removal. Ovulation was confirmed by laparoscopy at 54 and 72 h after sponge removal. A seasonal shift was detected in the intervals to onset of estrus, LH surge, and ovulation after sponge removal (P<0.05), with sponge removal to onset of estrus being shorter (P<0.05) in November (25.0 +/- 1.56 h) and July (28.9 +/- 2.43 h) than in March (40.9 +/- 3.27 h). The intervals between onset of estrus and the LH surge and between the LH surge and ovulation were found to be constant throughout the different seasons. An optimal time for breeding, artificial insemination, oocyte and embryo recovery, and embryo transfer may be predicted using information gained from these studies.

Administration, Intravaginal↗
PubMed1998

Estrus synchronization with lower dose of PGF2 alpha and subsequent fertility in subestrous buffalo.

Two experiments were conducted to determine luteal regression, estrous response and fertility in buffalo receiving cloprostenol via 2 routes of administration. In Experiment 1, cyclic buffalo (n = 10) were assigned to 2 equal groups receiving either 500 micrograms i.m. cloprostenol (Estrumate, ICI) or 125 micrograms cloprostenol injected intravulvosubmucosal (ivsm) ipsilateral to the side of the corpus luteum (CL) on Day 11 of an induced estrous cycle. Serum progesterone (P4) concentrations were evaluated immediately before treatment and at 24, 48, 72, 96 and 120 h after PGF2 alpha administration. The decline in serum P4 concentrations was significantly different (P < 0.05) between groups up to 48 hrs after treatment. However, no significant difference (P > 0.05) was observed for the interval from treatment to the onset of estrus (94.9 +/- 10.7 vs 96.0 +/- 15.9 h) for 500 or 125 micrograms of cloprostenol groups, respectively. In Experiment 2, multiparous, lactating subestrous buffaloes (n = 137) were treated either with 125 micrograms ivsm cloprostenol or 500 micrograms i.m. cloprostenol (n = 28 vs 33, respectively) during peak breeding (September-February) or low breeding (March-August) season (n = 37 vs 39, respectively). Buffalo observed in estrus were inseminated twice with frozen-thawed semen at 12 and 22 h after the onset of estrus. Buffalo that failed to exhibit estrus were given a second equal dose of cloprostenol at an 11-d interval and underwent fixed-time insemination at 72 and 96 h. The interval to the onset of estrus was 85.0 +/- 4.4 vs 73.2 +/- 2.6 h during peak breeding and 96.1 +/- 2.6 vs 92.1 +/- 3.8 h during the low breeding season for buffalo treated with 125 and 500 micrograms cloprostenol, respectively. These intervals were different (P < 0.05) between seasons but not between treatments in the same season. Conception rates of 47.8 vs 53.1% during peak breeding and 23.5 vs 25.6% during low breeding season were also different (P < 0.05) between seasons but not between the treatments in the same season for buffalo treated with 125 and 500 micrograms cloprostenol, respectively. These results indicated that 125 micrograms ivsm and 500 micrograms i.m. cloprostenol were equally effective for synchronizing estrus in subestrous buffalo. No negative effect of a lower dose of cloprostenol was observed on estrus synchrony and subsequent fertility; however, season of treatment had a significant effect on conception rates.

Animals↗
PubMed1995

An evaluation of estrus synchronization programs in reproductive management of dairy herds.

The objectives of this experiment were to evaluate the effect of various estrus synchronization programs on estrus detection rate (EDR) and pregnancy rate (PR) in lactating cows. Spring-calving, lactating dairy cows (n = 3,096) were allocated to one of six treatments: 1) PG (n = 514), estrus detection for 10 d before the onset of the breeding season (BS), cows detected in estrus received PGF2 alpha (PGF) 8 d after estrus, and all cows to be bred by d 11 of BS; 2) PG+EBZ (n = 510), as in PG plus cows treated with PGF received 1 mg of estradiol benzoate 48 h later; 3) C (n = 522), progestogen (controlled intravaginal drug release; CIDR) inserted per vaginum 10 d before BS for 8 d, PGF treatment on the day before CIDR removal, and AI within 6 d after CIDR withdrawal; 4) C+EBZ (n = 520), as in C, plus 10 mg of estradiol benzoate 10 d before BS; 5) C+BUS (n = 517), as in C plus 10 micrograms of buserelin on the day of CIDR insertion; or 6) CON (n = 513), no treatment, and a 32-d period of AI. Relative to other CIDR-treated groups, estradiol benzoate at the time of CIDR insertion reduced (P < .05) the EDR (C, 85.0%;C+EBZ, 75.9%; C+BUS, 88.5%). The PR to first AI was reduced (P < .05) by C compared with other treatments (PG, 60.9%; PG+EBZ, 57.2%; C, 46.6%; C+EBZ, 60.5%; C+BUS, 57.9%; CON, 60.1%). The interval from the onset of BS to AI and pregnancy was reduced (P < .05) by up to 9 d by estrus synchronization relative to controls (PG, 5.5 +/- .2 d; PG+EBZ, 5.2 +/- .2 d; C 1.7 +/- .1 d; C+EBZ, 2.3 +/- .1 d; C+BUS, 106 +/- .04d, CON, 10.4 +/- .3 d). In conclusion an 8-d progestogen-buserelin-PGF treatment resulted in the best overall estrus detection and pregnancy rates, which would be beneficial to a compact calving program.

Administration, Intravaginal↗
PubMed1997

Fertility in estrus-cycling and noncycling virgin heifers and suckled beef cows after induced ovulation.

A procedure was developed to either induce or synchronize ovulation in heifers and suckled cows. Beef females were assigned to two breeding programs: 1) two injections of prostaglandin F2alpha (PGF2alpha) given 14 d apart to synchronize estrus (PGF2alpha control; n = 179), with inseminations 12 to 16 h after detected estrus or at 80 h in the absence of estrus, or 2) two injections of PGF2alpha (d -14 and 0) plus 100 microg of GnRH on d -7 when 6 mg of norgestomet was implanted (PGF2alpha/NORG/GnRH treatment; n = 173). Implants were removed 24 h after the second PGF2alpha injection (d +1) and females were inseminated 12 to 16 h after detected estrus until 54 h after PGF2alpha. The remaining cattle were given a second 100-microg GnRH injection 54 h after PGF2alpha and inseminated 18 to 20 h later. Percentages of noncycling females with subsequently elevated progesterone (P4) on d 0 or +1 were not different between treatment groups (20.4 vs 25%), but conception rate was greater (P < .05) in noncycling treated females than in noncycling controls (55 vs 12.8%). Conception rates in cycling (59.2%) and noncycling (62.2%) treated females were similar to those in cycling controls (56.2%) but greater (P = .06) than those in noncycling controls (26.5%). Conception rates in treated females inseminated 12 to 16 h after detected estrus (63.1%) or at one fixed time (58.3%) were similar to those in controls inseminated 12 to 16 h after detected estrus (68.7%). This treatment procedure produced fertility after one timed insemination that was equal to controls inseminated after detected estrus and induced equally fertile ovulations in noncycling heifers and cows.

Aging↗
PubMed1984

Onset of estrus in dairy cows maintained indoors year-round.

During 6 mo two active testosterone-treated females fitted with chin-ball markers and paint were used to ascertain the time of onset of estrus in 56 cows of three genetic lines and at various stages of lactation. The two treated females were rotated every 24 h, and two colors of paint were used, one color for night, 1800 to 0600 h, and the other for day, 0600 to 1800 h. The incidence of behavioral signs of estrus, standing, mounting activity, and mucus discharge, also was recorded. More cows (65%) came into estrus during the night, and only 78% of the total marked cows, assumed to be in estrus, were observed standing by the herdsman, indicating that 22% of the cows would not have been observed in estrus by early morning and late afternoon observation by the herdsman. Similarly, of the marked cows a mucus discharge was observed for 60% and mounting activity by 62%. Neither parity nor days postpartum affected either time of onset of estrus or other overt signs of estrus. Differences among the genetic lines for standing and mounting activity were unexplained.

Animal Husbandry↗
PubMed1986

Synchronization of estrus in dairy heifers: a field demonstration.

Use of prostaglandin F2 alpha to synchronize estrus was demonstrated over 3 yr with 2966 dairy heifers in 45 herds. Reproductive status of all heifers was determined before any injections occurred. Anovulatory heifers (8.3%) were not injected or inseminated. Ovulatory heifers received one intramuscular injection and most heifers received two injections of prostaglandin F2 alpha spaced 11 d apart. Observations for estrus and insemination were scheduled and performed by dairy farmers. Insemination of heifers occurred 12 h after detection of estrus or at 80 h after second injection of prostaglandin F2 alpha. Pregnancy rate averaged 50.9% but varied from 0 to 100%. Pregnancy rate after insemination according to estrus (62.8%) was greater than when insemination was at 80 h (39.1%). Low pregnancy rates were associated with limitations in basic management of heifers before or during insemination. Managerial limitations were in timing insemination, range of ages or weights of heifers housed together, number and types of vaccinations, season and diet, frequency of observing heifers for estrus, and number of straws of semen thawed concurrently. Managerial factors that affect fertility are similar whether or not estrus is synchronized. Although agents used to synchronize estrus do not affect fertility directly, managerial limitations on fertility may be accentuated by increased intensity of activity associated with synchronization.

Animals↗
PubMed1989

Electrical conductivity of reproductive tissue for detection of estrus in dairy cows.

The pattern of temporal measurements of electrical conductivity obtained from electrodes that had been surgically implanted in the mucosa of the vagina or in the submucosa of the vulva in each of five dairy cows was evaluated for changes associated with the occurrence of estrus. Tissue conductivity was monitored at 6-h intervals during and around estrus by hard-ware devices operating at either 16 or 100 kHz. Blood samples were taken at time of conductivity measurement for progesterone determination and at 2-h intervals during estrus for LH determination. Vaginal and vulvar biopsies were performed during diestrus and estrus to measure tissue hydration. Conductivity increased significantly at estrus relative to a nonestrus base period in both vaginal and vulvar tissue. Both electrical frequencies were found to be satisfactory for characterizing changes in tissue conductivity associated with estrus. Peak concentrations of luteinizing hormone, increases in tissue hydration, and patterns of blood progesterone were consistent with the occurrence of estrus during the time of elevated tissue conductivity.

Animals↗
PubMed2000

Estrus and estrogen changes in mated and unmated free-living European ground squirrels.

The course of behavioral and vaginal estrus and patterns of circulating estrogens were followed in free-living European ground squirrels (Spermophilus citellus) after their emergence from hibernation. Normally mating females were compared to a second group in an area where males had been removed from the population before female emergence. Both groups showed vaginal estrus, but the patterns differed. Mating shortened vaginal estrus to a 3-day period compared to 8 days in unmated females. The extent (cell number) of cell cornification during estrus and the cellular components (percentage distribution) of metestrus did not differ between the two groups. Females in the area without males had significantly higher estrogen levels during estrus and metestrus compared to those in the control area. European ground squirrels were found to be monestrous, as none of the unmated females reentered estrus after metor diestrus was detected. The prolongation of vaginal estrus in unmated females can be viewed as either a physiological inevitability or an adaptation to low mate availability. The extension is still relatively short compared to other sciurid species and perhaps a product of constraints producing a strict time frame for reproduction.

Animals↗
PubMed2006

Influence of reproductive stage at PRID insertion on synchronization of estrus and ovulation in mares.

In the present study, we investigated the effects of reproductive status, size of follicles and plasma progesterone concentrations of mares at PRID insertion on the efficacy of the treatment, estrous cycle patterns, plasma concentrations of progesterone and LH. The progesterone-releasing device (PRID) was administered intravaginally to 28 Haflinger mares for 11 days at different reproductive stages: anestrus (n=6), estrus (n=11) and diestrus (n=11). Plasma concentrations of progesterone at insertion (Day 1) of PRID differed among treatment groups (anestrus: 0.2-0.6 ng mL(-1), estrus: 0.2-0.5 and diestrus: 1.6-10.8 ng mL(-1); P<0.001). Total secretion of progesterone (area under curve (AUC)) during treatment period revealed highest values in diestrus (38.2+/-3.1 ng mL(-1)h(-1)) followed by estrus (25.1+/-2.7) and anestrus (21.0+/-0.4 ng mL(-1)h(-1); P<0.05). Progesterone area under curve (AUC) was positively correlated with initial progesterone concentrations (R=0.5; P<0.05), but it did not correlate with the interval from PRID removal to ovulation. Plasma concentrations of LH during treatment period, were significantly lower in anestrous mares (184.6+/-28.6 ng mL(-1)h(-1)) when compared to estrous and diestrous mares (349.7+/-53.3 and 370.5+/-40.3 ng mL(-1)h(-1); P<0.05). Follicular size at PRID insertion had no effects on the intervals from PRID removal to subsequent estrus and ovulation. Follicle diameters at removal of PRID were significantly correlated with the interval from coil removal to estrus (R=-0.55, P<0.05) and ovulation (R=-0.72, P<0.0004) in cyclic mares. In anestrus 0 of 6 (0%) mares, in estrus 5 of 11 (45.5%) and in diestrus 6 of 11 (54.5%) mares ovulated within a defined interval of 1 day before to 1 day after mean interval from PRID removal to ovulation. In cyclic mares, response to treatment was significantly higher when compared to anestrous mares: almost all mares responded with estrus and ovulation independent from the stage of the estrous cycle at the start of treatment. However, accuracy of synchronization was still unsatisfactory. In cyclic mares, the plasma progesterone concentrations at insertion of PRID seem to be more important for the efficacy of the treatment than the assignment to estrous cycle stages.

Administration, Intravaginal↗
PubMed2006

Effects of ACTH injections during estrus on concentrations and patterns of progesterone, estradiol, LH, and inhibin alpha and time of ovulation in the sow.

This study investigated whether injections of ACTH for 48 h, from the onset of the second standing estrus after weaning, had any impact on time of ovulation and patterns of progesterone, estradiol, luteinizing hormone (LH), and inhibin alpha. The studied sows (n=15) were fitted with jugular vein catheters and randomly divided into a control (C group) and an ACTH group. From the onset of standing estrus, the sows were injected (NaCl or synthetic ACTH, 5 microg/kg) every 4h; blood samples were collected immediately before and 45 min after each injection. Ovulation was monitored using ultrasonography. The ACTH-group sows stopped displaying signs of standing estrus sooner after ovulation in their second estrus, but no impact was found on time of ovulation. There were no significant differences in the intervals between LH peak, estradiol peak, and the onset of standing estrus between the C and ACTH groups. The cortisol and progesterone concentrations were significantly elevated (p<0.001) in samples taken 45 min after ACTH injection. There were minor differences in estradiol and LH concentrations between the groups. Overall inhibin alpha concentrations were significantly higher during the treatment period in the ACTH than in the C group, but there were no significant differences between samples taken either 45 min or 4h after injection. In conclusion, injections of synthetic ACTH during estrus in the sow apparently disturb the duration of signs of standing estrus and the hormonal pattern of progesterone, and possibly of inhibin alpha, estradiol and LH.

Adrenocorticotropic Hormone↗
PubMed2005

Effect of a CIDR insert and flunixin meglumine, administered at the time of embryo transfer, on pregnancy rate and resynchronization of estrus in beef cattle.

The objectives of this study were to evaluate the effects of flunixin meglumine (FM), an inhibitor of PGF(2alpha) synthesis, and insertion of an intravaginal progesterone-releasing device (CIDR), on pregnancy rates in beef cattle embryo transfer (ET) recipients, and to examine the effect of a CIDR after embryo transfer on the synchrony of the return to estrus in non-pregnant recipients. Cows (n=622) and heifers (n=90) at three locations were assigned randomly to one of four groups in a 2x2 factorial arrangement of treatments with FM administration (500 mg i.m.) 2-12 min prior to ET, and insertion of a CIDR (1.38 g progesterone) immediately following ET as main effects. Fresh or frozen embryos (Stage=4 or 5; Grade=1 or 2) were transferred on Days 6-9 of the estrous cycle and CIDR devices were removed 13 days after ET. Recipients at Location 2 only were observed for signs of return to estrus. Recipients that returned to estrus at Location 2 were either bred by AI or received an embryo 7 days after estrus. Following the initial ET, there was an FMxlocation interaction on pregnancy rate (P<0.01; Location 1, 89% versus 57%; Location 2, 69% versus 64%; Location 3, 64% versus 67% for FM versus no FM, respectively). Pregnancy rates of embryo recipients were not affected by CIDR administration (P>0.05; 65% with CIDR, 70% without CIDR), however, the timing of the return to estrus was more synchronous (P<0.01) for recipients given a CIDR. Pregnancy rate of recipients bred following a return to estrus did not differ between cows receiving or not receiving a CIDR for resynchronization (P>0.13). Effects of FM on pregnancy rate were location dependent and CIDR insertion at ET improved synchrony of the return to estrus.

Administration, Intravaginal↗
PubMed2000

Reproductive performance of lactating dairy cows treated with cloprostenol, hcg and estradiol benzoate for synchronization of estrus followed by timed AI.

In previous studies, we demonstrated that the administration of a luteolytic dose of cloprostenol, followed by 750 IU hCG plus 3 mg estradiol benzoate (EB) 12 h later, synchronized estrus in cows in the luteal phase. Most cows were ready for service 48 h after the beginning of treatment. The objectives of this study were to evaluate the reproductive performance of lactating dairy cows treated with this method of estrus synchronization and to determine the effect of decreasing the hCG-EB dose on synchronization and pregnancy rates after timed AI. Data were obtained from cows first inseminated within an interval of 45 to 70 d postpartum. A total of 2,472 lactating dairy cows in their first to second lactation period were assigned to 4 groups. Cows estimated to be in the luteal phase by rectal palpation were treated with 500 mcg, im, of cloprostenol and assigned to 1 of 3 groups to be intramuscularly injected with hCG-EB 12 h later at the following doses: Group 1 (n=626), 250 IU of hCG and 1 mg of EB; Group 2 (n=592), 500 IU of hCG and 2 mg of EB; and Group 3 (n=664), 750 IU of hCG and 3 mg of EB. Cows displaying natural estrus were inseminated to serve as controls (n=590). The synchronized cows were inseminated 48 h after cloprostenol injection, and control animals visually determined to be in natural estrus during the morning or afternoon were inseminated the following morning. Pregnancy diagnosis was performed by rectal palpation at 34 to 40 d postinsemination. All synchronized cows showed estrous activity within 24 to 36 h after cloprostenol treatment and were considered to be ready for service 48 h after this treatment. There was a significant effect of treatment on the pregnancy rate, either to first AI or to 2 rounds of AI. The pregnancy rate in response to first or second rounds of AI was similar to control rates for cows in Groups 1 and 2, and lower than control rates in Group 3. Cows in Group 1 showed a higher pregnancy rate to first AI than those in Group 3 (P<0.0001), and a higher pregnancy rate to second AI rounds than cows in Groups 2 (P<0.02) and 3 (P<0.0001). The number of cows returning to estrus was unaffected by treatment. However, treatment significantly decreased (P<0.01) the time of return to estrus as the hCG-EB dose increased. These findings indicate that the lowest dose of hCG-EB treatment tested gave the overall best pregnancy results among the treated groups. Furthermore, the synchronization protocol used in this experiment allows effective AI management of lactating dairy cows without the need for estrus detection.

Animals↗
PubMed2003

Selective control of the estrous cycle of the dog through suppression of estrus and reduction of the length of anestrus.

The objective of this study was to determine the effectiveness of testosterone in suppressing estrus in the bitch, and of cabergoline in shortening the length of the subsequent anestrous period. In Experiment 1, 12 diestrual Beagle bitches were randomly divided into two groups when plasma progesterone (P(4)) concentration was <1 ng/ml (Day 0). Starting on Day 0, bitches in Group 1 (n=6) were treated with testosterone cypionate every 14 days for a total of 239 days, and bitches in Group 2 served as untreated controls. On Day 274, bitches in both groups were treated with cabergoline for 40 days and blood samples were obtained on Days 274, 276 and 279 for determination of plasma prolactin (PRL) concentrations using RIA. All bitches were observed for proestrual bleeding during treatment with cabergoline. In Experiment 2, 12 Greyhound bitches previously treated with testosterone within the last 6 months were randomly divided into two groups. At the initiation of this experiment, P(4) concentration was determined to verify that all bitches had a concentration of <1 ng/ml (Day 0). Starting on Day 0, bitches in Group 1 (n=6) were treated with cabergoline for 36 days, and bitches in Group 2 (n=6) served as untreated controls. Blood samples were obtained on Days 0, 2 and 5 to determine PRL concentrations. All bitches were observed for proestrual bleeding during treatment with cabergoline. In Experiment 1, one bitch (Group 1) exhibited estrus after treatment with testosterone (1mg/kg body weight) for 43 days, and one bitch (Group 1) exhibited estrus after treatment with testosterone (2mg/kg body weight) for 113 days. None of the other four bitches in Group 1 exhibited estrus during the period of testosterone treatment (239 days). All bitches in Group 2 (control) exhibited estrus during the 239 days of the study. In addition, five of the six testosterone-treated bitches showed signs of proestrual bleeding within an average of 12.6 days (range of 5-25 days) after treatment with cabergoline; and, four of the six nontestosterone bitches showed signs of proestrual bleeding within an average of 28 days (range of 6-46 days). Prolactin concentrations in bitches in both Groups 1 and 2 significantly decreased after treatment with cabergoline. In Experiment 2, one of the six bitches showed signs of proestrual bleeding within 15 days after treatment with cabergoline. From the results of this study, it was concluded that exogenous testosterone was moderately effective (66%) in suppressing estrus in Beagle bitches, and cabergoline was effective in shortening the length of the anestrous period of Beagle bitches whose estrous cycle was previously suppressed with exogenous testosterone, but less effective in shortening the length of the anestrous period in Greyhound bitches previously treated with testosterone to suppress estrus.

Anestrus↗
PubMed1998

Measurement of vaginal temperature by radiotelemetry for the prediction of estrus in beef cows.

Peaks in vaginal temperature were assessed as predictors of estrus in 22 suckled beef cows during 2 breeding seasons. A flexible plastic anchor was used to retain a temperature radiotransmitter within the cow vagina and vaginal temperature was monitored at 4-min intervals. Blood was collected twice weekly for analysis of serum progesterone to confirm the occurrence of estrus and ovarian status was checked weekly using transrectal ultrasonography. Visual observations of estrous behavior were made for 20 min/h between 0400 and 0800 h and casually from 0800 to 1600 h (4 to 6 times). Values for vaginal temperature were available for 47 estrous periods. The prediction of estrus based on vaginal temperature was excellent when an estral peak in vaginal temperature was defined as an increase of at least 0.4 degree C for 3 or more consecutive hours using the corresponding hourly means of a 2 or 3-d baseline. Combining the results of 2 separate years and using a 3-d baseline, a peak in vaginal temperature was found for 42 of 47 confirmed estrus periods (detection sensitivity of 89.4% and prediction power positive of 85.7%). Corresponding detection sensitivity and prediction power positive for visual observations of standing estrus were 53.2 and 96.2%, respectively. The mean maximal increase in vaginal temperature at estrus was 0.9 +/- 0.3 degree C and the mean duration of the estrual peak in vaginal temperature was 6.5 +/- 2.7 h. In addition, vaginal temperature was found to be significantly depressed for 3 d prior to estrus and significantly elevated at mid-cycle.

Animals↗
PubMed1975

Body weight and food intake at early estrus of rats on a high-fat diet.

Body weight, food intake, and age at vaginal opening and estrus were studied for two groups of weanling rats (age 21 days), fed on high-fat (24.6% by weight) and low-fat (5.0%) diets. Fat was substituted isocalorically for carbohydrate in the high-fat diet. The high-fat rats had estrus at 33.3 +/- 0.8 days, significantly earlier (P less than 0.001) than the age at estrus, 37.4 +/- 0.7 days, of the low-fat rats. Estrus was simultaneous with vaginal opening in 81% of the high-fat rats, in comparison to 48% of the low-fat rats. The caloric intake per 100 g of body weight of the high-fat and low-fat rats did not differ at vaginal opening or at estrus, whereas the two groups differed significantly at both events in age, body weight, absolute food intake (g/day), and relative food intake (g/100 g of body weight per day) and absolute caloric intake (calories/day). Caloric intake/100 g of body weight as a function of chronological age first increased and then decreased steadily before estrus for both high-fat and low-fat rats. The findings support Kennedy's hypothesis that a food intake signal, now further defined as caloric intake/100 g of body weight, is a signal for puberty, and are in accord with the hypothesis that a critical body composition of fatness is essential for estrus in the rat, as in the human female.

Age Factors↗
PubMed1977

Carcass components at first estrus of rats on high-fat and low-fat diets: body water, protein, and fat.

Carcass analysis data show that weanling rats fed high-fat (HF) and low-fat (LF) diets until the day of first estrus had similar body compositions at estrus, although the HF rats had estrus significantly earlier and at a lighter body weight (P less than 0.01) than the LF-diet rats. Total water as percent of wet weight, protein as percent of wet weight, and the water/protein ratios of the HF- and LF-diet rats did not differ significantly, whereas the absolute amounts of body water and protein of the two diet groups differed significantly (P less than 0.01), in accord with means (+/- SEM) of total body water as percent of wet weight were 66.2 +/- 0.3% for the HF rats and 66.4 +/- 0.3% for the LF-diet rats, whereas the mean absolute total body water for the two diet groups was 69.7 +/- 2.2 g and 81.1 +/- 2.4 g, respectively (P less than 0.01). Carcass fat of the HF rats, 15.6 +/- 1.0 g, was identical with that of the LF-diet rats, 15.6 +/- 0.9 g. The HF rats were therefore relatively fatter, 14.6 +/- 0.6 wet weight %, than the LF-diet rats, 12.6 +/- 0.4 wet weight % (0.05 greater than P greater than 0.01). The percentage of water in the fat-free wet weight of the HF rats, 77.5 +/- 0.3%, was significantly (P less than 0.01) greater than that of the LF-diet rats, 76.1 +/- 0.3%. These data and the high percentages of total water of body weight show that at first estrus the HF- and LF-diet rats had not as yet attained an adult body composition, similar to the human female at menarche. Within each diet group, the percentages of total water/body weight, protein/wet weight and fat/wet weight, or fat/dry weight, did not change significantly with increasing age of estrus, whereas each absolute carcass component--body water, protein, and fat--increased significantly with increasing age of estrus. The carcass data support G.C. Kennedy's hypothesis that a metabolic signal, related to fat stores, is a signal for puberty in the rat and are in accord with the hypothesis that a critical body composition of fatness is necessary for estrus in the rat, as in the human female. The greater relative fatness of the HF-diet rats may be associated with higher levels of estrogen in the HF rats than in the LF-diet rats.

Age Factors↗
PubMed1988

Estrogen induces estrus unaccompanied by a preovulatory surge in luteinizing hormone in suckled sows.

The objective was to determine if progressive changes occurred in incidence of estrus and patterns of luteinizing hormone (LH) after estradiol benzoate (EB) administration at three stages of lactation. Estradiol benzoate (800 micrograms) was injected at the beginning of the second (7.8 +/- 0.3 days, range 7-8, n = 4), third (15.6 +/- 0.3 days, range 15-16 days, n = 5), or fourth (23.3 +/- 0.5 days, range 22-24, n = 4) wk of lactation. Interval to estrus (h) and proportion in estrus (in parentheses) were 72 (1/4), 88.5 (4/5), and 99 (4/4; pooled SEM = 3.5) for the second, third, and fourth weeks, respectively. Only one animal ovulated during lactation (third week). This animal had a progesterone concentration of 17 ng/ml 1 wk after estrus and an LH concentration above 2.0 ng/ml for 72 through 90 h after EB. In other sows, LH remained less than 1.0 ng/ml after EB. Patterns of LH after EB in sows treated during the fourth week of lactation were increased to a maximum of 0.76 ng/ml by 120 h after EB, which was greater than for those treated during the second or third week (maxima of 0.38 and 0.32 ng/ml, respectively; pooled SEM = 0.07; p less than 0.05). Concentrations of LH in sows that exhibited estrus were greater both before and after treatment than in sows that did not exhibit estrus after EB (p less than 0.05). By 2 wk after weaning, 8 sows had ovulated (6 of these exhibited estrus), and there were no effects of stage of lactation on these responses. We concluded that the behavioral responsiveness to EB increased as lactation progressed. The increased LH in sows treated during the fourth week indicated a partial recovery of the positive feedback response to EB. These data suggested that separate mechanisms caused behavioral and gonadotropin responses to EB in lactating sows.

Animals↗
PubMed1997

Administration of testosterone from day 13 of the estrous cycle to estrus increased the number of corpora lutea and conceptus survival in gilts.

The effects of exogenous androgens on the number of corporea lutea (CL) and conceptus survival were examined in crossbred gilts. In Exp. 1, gilts received 1 mg of testosterone per day from d 13 (d = 0 first day of estrus, n = 21) or d 16 until estrus (n = 23). Gilts in the vehicle group received corn oil (n = 20). Gilts were mated and on d 11.5 their concepti and CL were evaluated. In Exp. 2, conceptus survival was examined at the 4- to 8-cell, early blastocyst or hatching blastocyst stages for gilts given vehicle or 1 mg testosterone from d 13 (24 gilts per group). In Exp. 3, gilts received 1 mg of androstenedione (n = 20) or vehicle (n = 18) per day from 13 d to estrus and then were mated and evaluated on d 11.5. Results from Exp. 1 indicated that the number of CL was greater (P < .04) in gilts treated with testosterone from d 13 to estrus than in gilts receiving vehicle (16.4 vs 14.8, respectively). Similarly, the number (P < .01) and recovery rate (P < .04) of blastocysts were greater in gilts treated with testosterone from d 13 to estrus than in gilts treated with testosterone from d 16 to estrus in gilts receiving vehicle (number, 15.3 vs 12.8 or 12.8; recovery rate, 95 vs 87 or 86%, respectively). Gilts treated testosterone or vehicle did not exhibit differences (P > .05) in number of normal concepti at the 4- to 8-cell and hatching stages. However, prior treatment with testosterone delayed conceptus death; gilts treated with testosterone had more (P < .01) normal concepti at the intermediate stage (early blastocyst) than those treated with vehicle (treatment x embryo stage interaction, P < .05). In Exp. 3, androstenedione treatment did not influence (P > .10) the number of CL or the number and recovery rates of d-11.5 blastocysts. Treating gilts with testosterone from d 13 of the estrous cycle to the following estrus increased the number of CL and blastocyst survival, perhaps by improving some, as yet unknown, aspect(s) of oocyte quality.

Androstenedione↗